Invesco’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $946K | Buy |
273,383
+88,552
| +48% | +$306K | ﹤0.01% | 2864 |
|
|
2025
Q1 | $484K | Buy |
184,831
+65,414
| +55% | +$171K | ﹤0.01% | 3150 |
|
|
2024
Q4 | $492K | Buy |
119,417
+5,261
| +5% | +$21.7K | ﹤0.01% | 3227 |
|
|
2024
Q3 | $808K | Sell |
114,156
-357
| -0.3% | -$2.53K | ﹤0.01% | 2996 |
|
|
2024
Q2 | $747K | Sell |
114,513
-2,370
| -2% | -$15.5K | ﹤0.01% | 3082 |
|
|
2024
Q1 | $970K | Sell |
116,883
-30,198
| -21% | -$251K | ﹤0.01% | 2998 |
|
|
2023
Q4 | $1.62M | Sell |
147,081
-6,227
| -4% | -$68.6K | ﹤0.01% | 2687 |
|
|
2023
Q3 | $1.29M | Buy |
153,308
+26,424
| +21% | +$222K | ﹤0.01% | 2744 |
|
|
2023
Q2 | $1.59M | Buy |
126,884
+52,931
| +72% | +$665K | ﹤0.01% | 2704 |
|
|
2023
Q1 | $1.22M | Buy |
73,953
+15,085
| +26% | +$248K | ﹤0.01% | 2821 |
|
|
2022
Q4 | $879K | Buy |
58,868
+1,061
| +2% | +$15.9K | ﹤0.01% | 2976 |
|
|
2022
Q3 | $1.29M | Buy |
57,807
+188
| +0.3% | +$4.21K | ﹤0.01% | 2818 |
|
|
2022
Q2 | $966K | Buy |
57,619
+4,293
| +8% | +$72K | ﹤0.01% | 2993 |
|
|
2022
Q1 | $1.6M | Buy |
53,326
+23,491
| +79% | +$703K | ﹤0.01% | 2854 |
|
|
2021
Q4 | $917K | Buy |
29,835
+2,440
| +9% | +$75K | ﹤0.01% | 3081 |
|
|
2021
Q3 | $864K | Buy |
27,395
+4,118
| +18% | +$130K | ﹤0.01% | 3146 |
|
|
2021
Q2 | $852K | Buy |
23,277
+13,725
| +144% | +$502K | ﹤0.01% | 3167 |
|
|
2021
Q1 | $330K | Buy |
9,552
+2,548
| +36% | +$88K | ﹤0.01% | 3495 |
|
|
2020
Q4 | $291K | Buy |
+7,004
| New | +$291K | ﹤0.01% | 3408 |
|